Al-Noshokaty T, Abdelhamid R, Abdelmaksoud N, Khaled A, Hossam M, Ahmed R
Toxicol Rep. 2025; 14:101895.
PMID: 39911322
PMC: 11795145.
DOI: 10.1016/j.toxrep.2025.101895.
Jin T, Chen Y
Cardiovasc Drugs Ther. 2024; 39(1):9-12.
PMID: 39470894
DOI: 10.1007/s10557-024-07630-9.
Parums D
Med Sci Monit. 2024; 30:e946675.
PMID: 39350608
PMC: 11453121.
DOI: 10.12659/MSM.946675.
Pandey A, Goyal A
Pharm Pat Anal. 2024; 13(1-3):73-89.
PMID: 39316579
PMC: 11449036.
DOI: 10.1080/20468954.2024.2366693.
Lenharo M
Nature. 2024; .
PMID: 39300267
DOI: 10.1038/d41586-024-03078-x.
Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides.
Nishida K, Ueno S, Seino Y, Hidaka S, Murao N, Asano Y
Nutrients. 2024; 16(14).
PMID: 39064713
PMC: 11280123.
DOI: 10.3390/nu16142270.
Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.
Abiola J, Oluyemi A, Idowu O, Oyinloye O, Ubah C, Owolabi O
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931402
PMC: 11206448.
DOI: 10.3390/ph17060736.
GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review.
Abubakar M, Nama L, Ansari M, Ansari M, Bhardwaj S, Daksh R
Curr Top Med Chem. 2024; 24(19):1635-1664.
PMID: 38803170
DOI: 10.2174/0115680266293416240515075450.
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein.
Heyns I, Arora M, Ganugula R, Allamreddy S, Tiwari S, Shah D
ACS Nano. 2024; 18(18):11863-11875.
PMID: 38622996
PMC: 11145941.
DOI: 10.1021/acsnano.4c01027.
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes.
Yen F, Hou M, Cheng-Chung Wei J, Shih Y, Hwu C, Hsu C
BMC Med. 2024; 22(1):8.
PMID: 38172833
PMC: 10765623.
DOI: 10.1186/s12916-023-03228-4.
Effect of Liraglutide on Fat Mass Percentage Among Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review.
Aladel A, Aljaouni J, Basaad R
Diabetes Metab Syndr Obes. 2023; 16:3381-3391.
PMID: 37915772
PMC: 10617533.
DOI: 10.2147/DMSO.S417374.
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists.
Ghosh P, Fontanella R, Scisciola L, Pesapane A, Taktaz F, Franzese M
Theranostics. 2023; 13(14):4872-4884.
PMID: 37771773
PMC: 10526673.
DOI: 10.7150/thno.86831.
Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies.
Kong F, Wu T, Dai J, Zhai Z, Cai J, Zhu Z
Front Pharmacol. 2023; 14:1205207.
PMID: 37771725
PMC: 10525376.
DOI: 10.3389/fphar.2023.1205207.
Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent.
Mehdi S, Pusapati S, Anwar M, Lohana D, Kumar P, Nandula S
Front Immunol. 2023; 14:1148209.
PMID: 37266425
PMC: 10230051.
DOI: 10.3389/fimmu.2023.1148209.
Ghrelin and glucagon-like peptide-1 according to body adiposity and glucose homeostasis.
Lopes K, da Silva Junior V, de Azevedo Marques Lopes F, Bouskela E, DE Souza M, Kraemer-Aguiar L
Arch Endocrinol Metab. 2023; 67(4):e000611.
PMID: 37252699
PMC: 10665067.
DOI: 10.20945/2359-3997000000611.
The human α cell in health and disease.
Pettway Y, Saunders D, Brissova M
J Endocrinol. 2023; 258(1).
PMID: 37114672
PMC: 10428003.
DOI: 10.1530/JOE-22-0298.
Short-term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice.
Feng J, Shao W, Jin T
Physiol Rep. 2023; 11(5):e15620.
PMID: 36905134
PMC: 10006666.
DOI: 10.14814/phy2.15620.
Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers.
Shin Y, Choi C, Oh E, Kim C, Park K, Park M
Drug Des Devel Ther. 2022; 16:4301-4310.
PMID: 36573067
PMC: 9789683.
DOI: 10.2147/DDDT.S383157.
Liraglutide Improves the Angiogenic Capability of EPC and Promotes Ischemic Angiogenesis in Mice under Diabetic Conditions through an Nrf2-Dependent Mechanism.
Yan X, Su Y, Fan X, Chen H, Lu Z, Liu Z
Cells. 2022; 11(23).
PMID: 36497087
PMC: 9736458.
DOI: 10.3390/cells11233821.
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury.
Pang J, Feng J, Ling W, Jin T
Acta Pharm Sin B. 2022; 12(11):4040-4055.
PMID: 36386481
PMC: 9643154.
DOI: 10.1016/j.apsb.2022.06.003.
